Leptospira Antibody Panel (IgG & IgM)

Leptospira Antibody Panel (IgG & IgM)

The Leptospira Antibody Panel (IgG & IgM) is a laboratory blood test that detects both Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies against Leptospira bacteria, the organisms responsible for leptospirosis. By measuring both antibody types, the test helps assess whether an individual has a recent, current, or previous Leptospira infection.

Leptospirosis is a zoonotic bacterial disease caused by pathogenic Leptospira species. Infection occurs when people come into contact with water, soil, or mud contaminated with the urine of infected animals, especially rats, cattle, pigs, and dogs. The bacteria enter the body through cuts or abrasions in the skin or through the eyes, nose, or mouth.

The disease is more common in areas with heavy rainfall, flooding, poor sanitation, agricultural work, sewage exposure, and freshwater recreational activities. Clinical illness ranges from a mild flu-like infection to severe disease affecting the kidneys, liver, lungs, heart, and brain (sometimes called Weil's disease in its severe form).

Common symptoms include:

• Sudden high fever
• Severe muscle pain, especially in the calves
• Headache
• Chills
• Red eyes (conjunctival suffusion)
• Nausea and vomiting
• Abdominal pain
• Jaundice
• Reduced urine output
• Fatigue

During infection, IgM antibodies generally become detectable 5–7 days after symptom onset, suggesting a recent or active infection. IgG antibodies appear later and may remain detectable for months or years, indicating previous exposure, past infection, or a later stage of disease.

Testing both antibodies together provides more clinical information than measuring either antibody alone. However, antibody testing cannot reliably detect infection during the first few days of illness, when antibodies have not yet developed. For patients with early symptoms, Leptospira PCR is often preferred, while the Microscopic Agglutination Test (MAT) remains the reference serological method for confirming leptospirosis.

Results should always be interpreted together with the patient's symptoms, exposure history, physical examination, and additional laboratory investigations.

Benefits of the Test

• Detects both IgM and IgG antibodies.
• Helps differentiate recent and previous infection.
• Supports diagnosis of leptospirosis.
• Requires only a simple blood sample.
• Useful in endemic areas and outbreak investigations.
• Complements PCR and MAT testing.
• Assists clinicians in treatment planning.
• Supports comprehensive infectious disease evaluation.

Why Doctors Recommend This Test

Doctors recommend the Leptospira Antibody Panel for patients with acute fever, muscle pain, jaundice, kidney dysfunction, recent floodwater exposure, occupational exposure, or suspected leptospirosis.

Preparation Before the Test

No special preparation is required.

You may eat and drink normally unless instructed otherwise. Inform your healthcare provider about recent travel, floodwater exposure, contact with animals, occupational risks, or current antibiotic treatment. A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 2–5 Working Days

Reporting time may vary depending on the laboratory methodology.

Who Should Take This Test?

This test may be recommended for:

• Individuals with unexplained fever.
• Patients with severe muscle pain.
• People exposed to floodwater.
• Farmers, veterinarians, and sewage workers.
• Patients with suspected leptospirosis.
• Individuals with jaundice or kidney problems.
• Travelers returning from endemic regions.
• Patients involved in outbreak investigations.
• Individuals referred by infectious disease specialists.
• Anyone advised by their healthcare provider.